A federal judge has approved Paramount’s settlement with a coalition of states challenging its Warner buyout, removing one of the most significant legal obstacles to the transaction’s closing. U.S. District Judge Araceli Martínez-Olguín found the proposed consent decree to be a fair resolution of the states’ allegations that the deal could harm competition.

For deal lawyers and antitrust practitioners, the ruling is notable not just because it keeps a major media-industry transaction on track, but because it underscores how merger challenges can be resolved through negotiated structural or behavioral commitments rather than prolonged injunction litigation.

A coalition of states has settled its challenge to the proposed $81 billion Paramount-Warner transaction, removing one of the most significant remaining legal threats to the deal. State officials, including Connecticut Attorney General William Tong and California officials, framed the resolution as a way to protect jobs and preserve editorial independence at major news organizations tied to the companies, even after the U.S. Justice Department chose not to step in.

The settlement is notable because it underscores the increasingly important role of state attorneys general in merger enforcement, particularly in politically sensitive industries such as media.

The Justice Department’s Antitrust Division has resumed a targeted Hart-Scott-Rodino review process, an important signal that federal merger scrutiny remains active and potentially more exacting for certain transactions. While this development is not tied to a single headline-grabbing court fight, it matters because the HSR process is the front door to U.S. merger enforcement: changes in how the government screens deals can directly affect closing timelines, regulatory strategy, and overall transaction risk.

The announcement from the U.S. Department of Justice Antitrust Division suggests that parties should expect renewed attention to selected reportable deals during the premerger review stage.

One of the most closely watched healthcare merger disputes is still the Justice Department’s challenge to UnitedHealth Group’s proposed acquisition of Amedisys — and, just as importantly, the government’s willingness to resolve that challenge through a divestiture package rather than insisting on an all-or-nothing court fight.

The proposed settlement, reached with the U.S. Department of Justice and a coalition of state attorneys general from Maryland, Illinois, New Jersey, and New York, would require substantial asset sales to address competitive concerns tied to home health and hospice markets.